Tag: Dynamx
EuroPCR 2026: DynamX bioadaptor demonstrates significantly lower event rates than drug-eluting stent
Elixir Medical has announced four-year results from the large 445-patient BIOADAPTOR randomised cont...
DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation
Elixir Medical has announced that its novel bioadaptive implant, the DynamX sirolimus-eluting co...
INFINITY-SWEDEHEART trial of DynamX bioadaptor system completes enrolment
Elixir Medical has announced enrolment completion in INFINITY-SWEDEHEART, a prospective, multice...
Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant
Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...
TCT 2017: Elixir reveals new drug-eluting stent
Elixir Medical unveiled for the first time its novel stent technology—Dynamx—at the 2017 Transca...
